<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F4EA387A-E17F-480F-9E7A-5C78C6BCD9DB"><gtr:id>F4EA387A-E17F-480F-9E7A-5C78C6BCD9DB</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Cherepanov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600009"><gtr:id>AAD0F294-5B49-408A-B4AD-ACB0B0F03C8A</gtr:id><gtr:title>LEDGF/p75 in retroviral DNA integration: from structure to function to potential applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600009</gtr:grantReference><gtr:abstractText>Akin to other retroviruses, HIV must insert a DNA replica of its genome into a human chromosome. Retroviral DNA integration defines a step of no return in the life cycle of the virus and the infected cell, the cell becoming a permanent carrier of the provirus (i.e. integrated copy of the viral genome). This feature contributes to the virus? persistency and later progression to AIDS. However, it also makes HIV and other retroviruses natural gene delivery vehicles for permanent repair of genetic disorders. Unfortunately, uncontrolled integration of modified retroviruses or ?vectors? can result in disruption or untuning of important genes and lead to cancer. Thus, insertion of a retroviral vector in proximity of the LMO2 gene is thought to be the cause of leukemias that affected three out of eleven children that participated in an X-SCID (X chromosome-linked severe combined immunodeficiency, also known as ?Bubble Boy Disease?) gene therapy trial. 
 Although the essential enzymatic steps associated with integration are orchestrated by virally-encoded enzyme integrase, many cellular factors are recruited by the virus to aid the intracellular transport, protection and finally homing of the viral integration machinery onto a suitable region of the host cell chromosomal DNA. LEDGF is a human chromosome-associated protein that has been extensively implicated in integration of HIV and related non-primate viruses. LEDGF binds integrase protein with high affinity and is capable of increasing its activity as much as 150-fold. In cells, LEDGF can protect HIV integrase from degradation and tether the viral protein to chromosomal DNA. All available data strongly indicate that LEDGF is directly involved in targeting HIV integration machinery into actively expressed genes. 
Recent biochemical and structural studies conducted by the applicant explained some key aspects of the LEDGF-IN recognition. The current research project is aimed to explain mechanism of LEDGF-mediated activation of integration and its selectivity towards a specific subset of retroviruses (lentiviridae). To this end we will try to obtain crystals and determine molecular structures of various integrase-LEDGF complexes. The study will further our understanding of the role that LEDGF plays in retroviral replication. We will also attempt to tailor LEDGF protein to re-target HIV integration machinery to a predefined spot of the human genome, a step towards creating safer gene therapy vectors.</gtr:abstractText><gtr:technicalSummary>Integration of a DNA replica of the viral genome into a host cell chromosome, an obligatory step of HIV replication, is orchestrated by virus-derived integrase (IN). Transcriptional co-activator LEDGF/p75 is the dominant cellular binding partner of HIV-1 integrase (IN) as well as other lentiviral INs. In human cells, endogenous LEDGF dictates sub-cellular distribution of ectopically expressed HIV-1 IN and tethers the viral protein to chromatin. During infection, LEDGF associates with lentiviral preintegration complexes. A significant reduction of HIV-1 integration into transcription units was observed under conditions of LEDGF/p75 depletion, directly implicating the host factor into lentiviral integration site selection. 
 Recent biochemical and structural studies conducted by the applicant explained many key aspects of the LEDGF-IN recognition and provided the basis for further research into the role of LEDGF in retroviral replication and possibly exploitation of LEDGF as a targeting factor for gene therapy applications. During three years of the proposed project we will address the structural basis for the modulation of the IN enzymatic activities by LEDGF and for the observed lentiviral tropism of the co-factor. Based on the available structural information we will carry out further genetic analyses of the LEDGF function(s) in viral replication. This proposal is aimed to provide the necessary foundation for future exploitation of the host factor in development of safer lentiviral vectors.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-15</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>445984</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Academic presentation to HIV clinicians and allied medical professions</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A2B89797-D49B-487A-8FCB-7E5A2157436C</gtr:id><gtr:impact>Presentation of current research to HIV clinicians and allied medical professions.

This lecture was part of our effort to bring the clinical service closer to the research and vice versa. Coordinated by Dr. Graham P. Taylor.</gtr:impact><gtr:outcomeId>FFBCB657147</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8AC4337C-0F91-45C5-A90D-D51AC30EFFC1</gtr:id><gtr:outcomeId>9B5B18DF9CB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BAE3D73B-9D31-4E52-BB52-025E83275237</gtr:id><gtr:title>The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>c7fL6MDBnKP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C68E33F-4513-43C8-8EC5-CD4845A8FA78</gtr:id><gtr:title>HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9ff52e24b05f5b2cf2786523be6ff84"><gtr:id>d9ff52e24b05f5b2cf2786523be6ff84</gtr:id><gtr:otherNames>Zaitseva L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>273D39DCAED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96711DE-1CAF-4F54-8E98-7E983439178F</gtr:id><gtr:title>Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69df773c643fd4394faef6039c278245"><gtr:id>69df773c643fd4394faef6039c278245</gtr:id><gtr:otherNames>Hughes S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>6AFE46293B5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7EB7F5C-7B2B-4761-B35D-BBD83751784A</gtr:id><gtr:title>Application of general formulas for the correction of a lattice-translocation defect in crystals of a lentiviral integrase in complex with LEDGF.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>153F1B7F9E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>700D5F03-DF9D-4806-9010-81C698E69B65</gtr:id><gtr:title>Functional and structural characterization of the integrase from the prototype foamy virus.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8052dc958bb199668ea5cf44fab03d60"><gtr:id>8052dc958bb199668ea5cf44fab03d60</gtr:id><gtr:otherNames>Valkov E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>7E22FBD898C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>720F0D34-349A-4B76-BC51-05CAC49C82F5</gtr:id><gtr:title>LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2459210727b755d74eb3437f6b1b30aa"><gtr:id>2459210727b755d74eb3437f6b1b30aa</gtr:id><gtr:otherNames>Cherepanov P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>79176F3290B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A754ED9D-2478-405B-A778-85A64F8CEB52</gtr:id><gtr:title>LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77e8ef3dc3871ba583784c993bd989e1"><gtr:id>77e8ef3dc3871ba583784c993bd989e1</gtr:id><gtr:otherNames>Shun MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>AFB17164FF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5466B8B7-DA50-4783-90E6-B47F2DF34B1D</gtr:id><gtr:title>The SET complex acts as a barrier to autointegration of HIV-1.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e51dd9f15f2953db792dca2a9539d2eb"><gtr:id>e51dd9f15f2953db792dca2a9539d2eb</gtr:id><gtr:otherNames>Yan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>3E9ABC47729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18774BF8-68B9-42C6-919C-2940EDBD27DC</gtr:id><gtr:title>The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7556856c4f70836893ec054ab43f8aab"><gtr:id>7556856c4f70836893ec054ab43f8aab</gtr:id><gtr:otherNames>Engelman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>E200A0126B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A3A12B4-8D5C-4C21-AF7C-1BB0EBD30F2D</gtr:id><gtr:title>Structural basis for functional tetramerization of lentiviral integrase.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>CBB91A47370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64D00803-7865-4227-8C96-92EF9A417DAB</gtr:id><gtr:title>A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>8B99E2BC91F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600009</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>